Evidence map›Paper›PMID 36045786›Full record

ArticleAnnals of medicine and surgery (2012)2022

Diclofenac induced anaphylaxis: A case report from Nepal.

Himal Bikram Bhattarai, Sangam Shah, Manish Uprety, Santosh Baniya, Gyabina Maharjan, Anshu Priya, Prabesh Bikram Singh, Ayusha Subedi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Himal Bikram BhattaraiGandaki Medical College and Teaching Hospital, Pokhara, Nepal.
Sangam ShahTribhuvan University, Institute of Medicine, Maharajgunj, 44600, Nepal.
Manish UpretyKathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Santosh BaniyaMetrocity Hospital, Pokhara, Nepal.
Gyabina MaharjanDepartment of Internal Medicine, Kirtipur Hospital, Kathmandu, Nepal.
Anshu PriyaJanaki Medical College, Janakpur, Nepal.
Prabesh Bikram SinghAll Nepal Hospital, Samakhusi, Nepal.
Ayusha SubediManmohan Memorial Community Hospital, Jhapa, Nepal.
Janaki Medical CollegeGreen Pastures Hospital and Rehabilitation Centre · NPKathmandu University · NPManmohan Memorial Institute of Health Sciences · NPPatan Hospital · NPTribhuvan University Teaching Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Diclofenac is considered a generally safe medication, and cause few side effects like dyspepsia, diarrhea/constipation, nausea, and vomiting, stomach bleeding, rash, urticaria, photosensitivity reactions, acute renal failure, analgesic nephropathy, bone marrow and liver diseases. Rarely, it causes anaphylactic reaction. Case presentation: We report a case of 40 years male who developed anaphylactic reaction after intravenous infusion with diclofenac. Discussion: Both the pulmonary embolism and anaphylaxis guidelines emphasize the importance of a thorough evaluation when making a diagnosis. Mast cells secrete tryptase, a neutral protease that is specifically concentrated in the secretory granules of human mast cells (but not basophils), along with histamine, as a marker of mast cell activation. Conclusion: Although intravenous diclofenac sodium is a safe and often used medicine, it can cause severe and perhaps fatal anaphylactic responses.

Indexed as

AnaphylaxisDiclofenacIntravenous

Identifiers

PMID36045786
PMCPMC9422281
OpenAlexW4288926662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.